Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/133158
Title: CELL-BASED CANCER IMMUNOTHERAPY: FROM ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO DENDRITIC CELLS THERAPEUTIC VACCINATION
Authors: TAN WEE KIAT
Keywords: Cancer Immunotherapy, Dendritic cell vaccine, Antibody-dependent cellular cytotoxicity, natural killer cells, gamma delta T cells, cancer stem cells
Issue Date: 18-Aug-2016
Citation: TAN WEE KIAT (2016-08-18). CELL-BASED CANCER IMMUNOTHERAPY: FROM ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO DENDRITIC CELLS THERAPEUTIC VACCINATION. ScholarBank@NUS Repository.
Abstract: In recent years, cancer immunotherapy has been shown as a promising cancer treatment strategy for cancer treatment. Antibody-dependent cellular cytotoxicity (ADCC) uses tumour-antigen specific antibodies to identify target cells before the infusion of effector cells to elicit anti-tumour effects. Recently, researchers found that γδT cells have similar receptors expression and anti-tumor functions with Natural Killer (NK) cells. Therefore, we aim to study the potential of γδT cells as an alternative effector cell type to NK cells for use in ADCC. Cancer stem cells (CSC) are widely attributed for cancer relapse. CSCs are reported to overexpress Oct4 and Sox2 genes to maintain stemness and can be used as antigens for CSC targeting. We attempt to generate DC vaccines targeting Oct4 and Sox2 genes through Baculovirus-mediated full-length gene delivery of Oct4 and Sox2. This DC vaccine would be capable of producing Oct4 and Sox2 antigen targeting cytotoxic T lymphocytes for CSC targeting.
URI: http://scholarbank.nus.edu.sg/handle/10635/133158
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
TAN Wee Kiat TANWK.pdf4.62 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

44
checked on Feb 1, 2019

Download(s)

2
checked on Feb 1, 2019

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.